A Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or Poor Metabolizers

Conditions: Gaucher ' s Disease Interventions: Drug: Eliglustat Sponsors: Sanofi Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials